Antares Pharma, Inc.
Antares Pharma, Inc. lists 11 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 18657-117 | HYLENEX Recombinant Injection, Solution | Hyaluronidase (human Recombinant) 150 [USP'U]/mL | Rx |
| 54436-010 | Otrexup Injection, Solution | Methotrexate 10 mg/.4mL | Rx |
| 54436-012 | Otrexup Injection, Solution | Methotrexate 12.5 mg/.4mL | Rx |
| 54436-015 | Otrexup Injection, Solution | Methotrexate 15 mg/.4mL | Rx |
| 54436-017 | Otrexup Injection, Solution | Methotrexate 17.5 mg/.4mL | Rx |
| 54436-020 | Otrexup Injection, Solution | Methotrexate 20 mg/.4mL | Rx |
| 54436-022 | Otrexup Injection, Solution | Methotrexate 22.5 mg/.4mL | Rx |
| 54436-025 | Otrexup Injection, Solution | Methotrexate 25 mg/.4mL | Rx |
| 54436-200 | Xyosted Injection | Testosterone Enanthate 100 mg/.5mL | Rx |
| 54436-250 | Xyosted Injection | Testosterone Enanthate 50 mg/.5mL | Rx |
| 54436-275 | Xyosted Injection | Testosterone Enanthate 75 mg/.5mL | Rx |